Target intelligence / Profile preview

Bacterial DNA and DNA-dependent enzyme

Molecular classification
Enzyme, DNA polymerase, DNA ligase, RNA polymerase, Topoisomerase, Other
01

Overview

The term "Bacterial DNA and DNA-dependent enzymes" collectively refers to a group of **enzymes in bacteria responsible for the metabolism of DNA**, including replication, repair, recombination, and transcription. Notable enzymes in this group include **DNA polymerases** (which synthesize new DNA strands and are essential for genome duplication)[5][7], **DNA ligases** (which seal breaks in the DNA backbone during replication and repair, utilizing either NAD^+^ or ATP as a cofactor)[1][2][4][6], **DNA topoisomerases** (which manage DNA supercoiling and untangling), and **RNA polymerase** (which transcribes DNA into RNA for gene expression)[3]. These enzymes are fundamental for bacterial survival and genomic maintenance. Many of them serve as **therapeutic targets for antibiotics**, such as rifampicin (which inhibits bacterial RNA polymerase) and fluoroquinolones (which inhibit bacterial DNA gyrase/topoisomerase). Some, like NAD^+^-dependent DNA ligases, are essential for bacterial viability and have been studied as potential antibiotic targets[6]. The various classes of these enzymes can possess different functions in distinct bacterial species and may localize to different cellular compartments. The term is **overly broad** as a therapeutic target and does not specify a single molecule, but rather a functionally related group of essential bacterial enzymes, each of which can be targeted individually by specific drugs[1][5][3][6][4][7].\n\n**Note:**\n- The target name as given is **not standard, highly non-specific, and represents a functional group rather than a discrete molecular entity**. Every bacterial species encodes multiple, distinct DNA-dependent enzymes, each with unique biochemical properties, druggability, and roles in physiology/disease[1][2][4][5][6][3][7].\n- For structured data or drug discovery purposes, it is critical to reference and classify each **individual enzyme** (e.g., "Bacterial DNA gyrase subunit A", "Bacterial NAD^+^-dependent DNA ligase", "Bacterial multisubunit RNA polymerase", etc.) rather than the generic category "Bacterial DNA and DNA-dependent enzymes."\n\n**Summary (as requested for structured extraction):**\n- The input target is **too broad, not a single canonical molecule, and should be replaced by more specific enzyme targets**.\n- Nevertheless, many essential bacterial DNA-dependent enzymes (polymerases, ligases, RNA polymerase, etc.) are validated therapeutic targets for antibacterial drugs.

Other names
DNA metabolic enzymesDNA replication and repair enzymesDNA-dependent proteins
02

Mechanism of action

Inhibition of DNA replication (by targeting DNA polymerases)[7][5]; Inhibition of DNA repair (by targeting DNA ligases, polymerases, topoisomerases)[6][1][2][4]; Inhibition of transcription (by targeting bacterial RNA polymerase)[3]; DNA strand breakage or inhibition of DNA joining (by targeting DNA ligases)[1][2][4][6]

03

Biological functions

DNA replicationDNA repairTranscriptionRecombinationChromosome maintenanceGene expression
04

Disease associations

InfectionAntibacterial targetDNA damage responseAntibiotic resistanceOther
05

Safety considerations

Essentiality for bacterial cell viability can lead to strong selective pressure and rapid resistance development[3][5]Drugs targeting bacterial DNA and DNA-dependent enzymes may also affect mitochondrial or host enzymes, leading to off-target toxicity (less frequent with current antibiotics but relevant for broad-spectrum or non-specific inhibitors)Potential mutagenic effects of agents interfering with DNA metabolism[3][4][5]Development of resistance via mutations in target enzymes
06

Interacting drugs

Rifampicin (inhibits bacterial RNA polymerase)[3]

7 more in the full profile.

07

Biomarkers

Expression or mutation status of DNA polymerase subunits in pathogensRNAP mutation (confers rifampicin resistance)[3]DNA gyrase mutations (confers fluoroquinolone resistance)Ligase gene or protein expression (novel/experimental)Other molecular markers of DNA-dependent enzyme activity or resistance

Beyond the preview

Go deeper on Bacterial DNA and DNA-dependent enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA and DNA-dependent enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call